ATE372990T1 - Oxazolderivat und deren verwendung als insulinsensibilisatoren - Google Patents
Oxazolderivat und deren verwendung als insulinsensibilisatorenInfo
- Publication number
- ATE372990T1 ATE372990T1 AT03762516T AT03762516T ATE372990T1 AT E372990 T1 ATE372990 T1 AT E372990T1 AT 03762516 T AT03762516 T AT 03762516T AT 03762516 T AT03762516 T AT 03762516T AT E372990 T1 ATE372990 T1 AT E372990T1
- Authority
- AT
- Austria
- Prior art keywords
- insulin sensitizers
- oxazole derivatives
- oxazole
- sensitizers
- insulin
- Prior art date
Links
- 229940122355 Insulin sensitizer Drugs 0.000 title 1
- 150000007978 oxazole derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02014828 | 2002-07-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE372990T1 true ATE372990T1 (de) | 2007-09-15 |
Family
ID=29797151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03762516T ATE372990T1 (de) | 2002-07-03 | 2003-06-26 | Oxazolderivat und deren verwendung als insulinsensibilisatoren |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6747049B2 (de) |
| EP (1) | EP1519925B1 (de) |
| JP (1) | JP4290648B2 (de) |
| KR (1) | KR100621294B1 (de) |
| CN (1) | CN100402510C (de) |
| AR (1) | AR040359A1 (de) |
| AT (1) | ATE372990T1 (de) |
| AU (1) | AU2003249879B2 (de) |
| BR (1) | BR0312452A (de) |
| CA (1) | CA2490152C (de) |
| DE (1) | DE60316290T2 (de) |
| ES (1) | ES2291688T3 (de) |
| MX (1) | MXPA04012840A (de) |
| PL (1) | PL374818A1 (de) |
| RU (1) | RU2295520C2 (de) |
| WO (1) | WO2004005266A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2277142T3 (es) * | 2002-08-30 | 2007-07-01 | Japan Tobacco Inc. | Compuesto de dibencilamina y su uso medicinal. |
| CN101007790B (zh) * | 2006-01-27 | 2011-03-30 | 北京摩力克科技有限公司 | 草氨酸衍生物、其制备方法和医药用途 |
| CA2640608A1 (en) * | 2006-02-01 | 2007-08-09 | Merck & Co., Inc. | Potassium channel inhibitors |
| US20190350955A1 (en) | 2016-06-30 | 2019-11-21 | Inserm (Institut National De La Sante Et De La Recherche Medicale | Methods and pharmaceutical compositions for the treatment of cardiomyopathies |
| WO2020201263A1 (en) | 2019-04-01 | 2020-10-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment and prevention of cardiac remodeling |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4011326A (en) | 1975-07-29 | 1977-03-08 | Merck & Co., Inc. | 2-Substituted oxazolo[4,5-b]pyridine anti-inflammatory agents |
| US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| TW222626B (de) * | 1991-07-22 | 1994-04-21 | Pfizer | |
| GB9225386D0 (en) | 1992-12-04 | 1993-01-27 | Smithkline Beecham Plc | Novel compounds |
| DE4317320A1 (de) | 1993-05-25 | 1994-12-01 | Boehringer Mannheim Gmbh | Neue Thiazolidindione und diese enthaltende Arzneimittel |
| GB9326171D0 (en) | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Novel compounds |
| GB9600464D0 (en) | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
| ZA9711051B (en) | 1996-12-10 | 1999-06-09 | Bristol Myers Squibb Co | Benzodioxole benzofuran dihydrobenzofuran and benzodioxane melatonergic agents |
| DE19711616A1 (de) | 1997-03-20 | 1998-09-24 | Boehringer Mannheim Gmbh | Verbessertes Verfahren zur Herstellung von Thiazolidindionen |
| US6121397A (en) | 1997-07-14 | 2000-09-19 | Xerox Corporation | Polymerization processes using oligomeric compound, monomer and surfactant |
| HN1998000118A (es) | 1997-08-27 | 1999-02-09 | Pfizer Prod Inc | 2 - aminopiridinas que contienen sustituyentes de anillos condensados. |
| DE69815008T2 (de) | 1997-09-19 | 2004-04-01 | Ssp Co., Ltd. | Alfa-substituierte Phenylpropionsäurederivate und diese enthaltende Arzneimittel |
| EP1073643B1 (de) | 1998-04-23 | 2004-12-29 | Dr. Reddy's Laboratories Ltd. | Heterozyklische verbindungen,und deren verwendung in arzneimittel,verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen |
| GB9817118D0 (en) | 1998-08-07 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
| GB9914977D0 (en) * | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
| PT1078923E (pt) | 1999-08-02 | 2006-07-31 | Hoffmann La Roche | Processo para a preparacao de derivados de benzotiofeno |
| US6930120B2 (en) | 2000-08-23 | 2005-08-16 | Eli Lilly And Company | Oxazolyl-arylproplonic acid derivatives and their use as ppar agonists |
-
2003
- 2003-06-26 JP JP2004518577A patent/JP4290648B2/ja not_active Expired - Fee Related
- 2003-06-26 MX MXPA04012840A patent/MXPA04012840A/es active IP Right Grant
- 2003-06-26 AU AU2003249879A patent/AU2003249879B2/en not_active Ceased
- 2003-06-26 DE DE60316290T patent/DE60316290T2/de not_active Expired - Lifetime
- 2003-06-26 CA CA002490152A patent/CA2490152C/en not_active Expired - Fee Related
- 2003-06-26 ES ES03762516T patent/ES2291688T3/es not_active Expired - Lifetime
- 2003-06-26 PL PL03374818A patent/PL374818A1/xx unknown
- 2003-06-26 WO PCT/EP2003/006726 patent/WO2004005266A1/en not_active Ceased
- 2003-06-26 BR BR0312452-5A patent/BR0312452A/pt not_active IP Right Cessation
- 2003-06-26 RU RU2005102817/04A patent/RU2295520C2/ru not_active IP Right Cessation
- 2003-06-26 KR KR1020057000046A patent/KR100621294B1/ko not_active Expired - Fee Related
- 2003-06-26 CN CNB038159147A patent/CN100402510C/zh not_active Expired - Fee Related
- 2003-06-26 EP EP03762516A patent/EP1519925B1/de not_active Expired - Lifetime
- 2003-06-26 AT AT03762516T patent/ATE372990T1/de active
- 2003-07-01 US US10/611,139 patent/US6747049B2/en not_active Expired - Fee Related
- 2003-07-01 AR ARP030102382A patent/AR040359A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP4290648B2 (ja) | 2009-07-08 |
| KR20050025303A (ko) | 2005-03-14 |
| RU2295520C2 (ru) | 2007-03-20 |
| MXPA04012840A (es) | 2005-02-24 |
| JP2005535647A (ja) | 2005-11-24 |
| EP1519925B1 (de) | 2007-09-12 |
| AU2003249879B2 (en) | 2008-12-18 |
| AU2003249879A1 (en) | 2004-01-23 |
| EP1519925A1 (de) | 2005-04-06 |
| CA2490152C (en) | 2009-04-07 |
| DE60316290T2 (de) | 2008-06-12 |
| US20040006116A1 (en) | 2004-01-08 |
| CN1668606A (zh) | 2005-09-14 |
| BR0312452A (pt) | 2005-04-19 |
| CA2490152A1 (en) | 2004-01-15 |
| RU2005102817A (ru) | 2005-11-20 |
| AR040359A1 (es) | 2005-03-30 |
| US6747049B2 (en) | 2004-06-08 |
| WO2004005266A1 (en) | 2004-01-15 |
| KR100621294B1 (ko) | 2006-09-06 |
| PL374818A1 (en) | 2005-10-31 |
| CN100402510C (zh) | 2008-07-16 |
| ES2291688T3 (es) | 2008-03-01 |
| DE60316290D1 (de) | 2007-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2013027I2 (el) | Νεα παραγωγα ινσουλινης | |
| ATE395339T1 (de) | Biphenylderivate und deren verwendung als fungizide | |
| ATE426597T1 (de) | Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel | |
| ATE346056T1 (de) | Substituierte phenylacetamide und deren verwendung als glucokinaseaktivatoren | |
| ATE403654T1 (de) | Benzimidazol-, benzothiazol- und benzoxazolderivate und deren verwendung als lta4h-modulatoren | |
| ATE430145T1 (de) | 3-ä(2-ä 4-(hexyloxycarbonylamino-imino-methyl)- phenylaminoü-methylü-1-methyl-1h-benzimidazol-5 carbonyl)-pyridin-2-yl-aminoü -propionsäure- ethylester -methansulfonat und dessen verwendung als arzneimittel | |
| DE50312295D1 (de) | 8-ä3-amino-piperidin-1-ylü -xanthine, deren herstellung und deren verwendung als arzneimittel | |
| DE60335151D1 (de) | Pyrimidinderivate und deren Verwendung als CB2-Modulatoren | |
| DE60202876D1 (de) | 6 aryl 4 aminopicolinate und deren verwendung als herbizide | |
| DE60328087D1 (de) | Aryl substituierte pyrimidine und deren verwendung | |
| ATE381335T1 (de) | 2-cyanopyrrolopyrimidine und deren pharmazeutische verwendung | |
| DE60303440D1 (de) | Benzoxazinonderivate, deren herstellung und deren verwendung als medikamente | |
| DE60323754D1 (de) | Dioxan-2-alkylkarbamaten derivaten, deren herstellung und deren therapeutischen verwendung | |
| EP1469860A4 (de) | Antikrebskombination und deren verwendung | |
| ATE316523T1 (de) | Benzoxazinderivate als 5-ht6-modulatoren und deren verwendungen | |
| DE50206476D1 (de) | Cyanoanthranylamid-derivate und deren verwendung als arzneimittel | |
| ATE371653T1 (de) | Benzoxazinderivate und deren verwendungen | |
| DE602004010284D1 (de) | Aminochinolinderivate und deren verwendung als adenosin-a3-liganden | |
| DE60311598D1 (de) | Naphthyridin-derivate und ihre verwendung als fungizide | |
| DE60322926D1 (de) | Photopolymerisierbare zusammensetzung und verwendung davon | |
| ATE555097T1 (de) | 4-cycloalkyl-substituierte tetrahydrochinolinderivate und deren verwendung als medikamente | |
| DE50313185D1 (de) | 2-pyrrolidin-2-yl-ä1,3,4ü -oxadiazol-derivate und ihre verwendung als antidepressiva | |
| ATE372990T1 (de) | Oxazolderivat und deren verwendung als insulinsensibilisatoren | |
| DE602004022169D1 (de) | Tetrahydrocarbazolderivate und deren pharmazeutische verwendung | |
| EP1553101A4 (de) | N-acetylglucosaminderivate und deren verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1519925 Country of ref document: EP |